The study covered a drug driver system that can be used for continuous glucose monitoring system intended to drive a pump that will administer insulin for the purpose of combating diabetes. The system ...

Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated ...

In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) ...

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

The endocrinologist and researcher was one of several investigators who presented Phase 3 clinical trial results at the 85th Scientific Sessions of the American Diabetes Association for a long-lasting ...

Eli Lilly is looking to approach regulators for approval of its once-weekly insulin for type 2 diabetes (T2D) after it proved ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

One of the more difficult decisions for patients with poorly controlled type 2 diabetes, as well as for their clinicians, is ...

Objectives During the COVID-19 pandemic, addiction treatment services received official guidance asking them to limit face-to-face contact with patients and to prescribe opioid agonist treatment (OAT) ...

These devices allow patients to self-administer insulin with minimal training, reducing dependence on healthcare providers. The growing awareness of diabetes care, improved healthcare infrastructure ...